Y-Mabs TherapeuticsYMAB
13F holders, Q3 2025 (September 30)2holders −95
0new positions
95sold out
$4.78avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Y-Mabs Therapeutics Inc. (YMAB) in their 13F filings, down 95 from Q2 2025. 0 opened new positions and 95 sold out. The largest holders were Brooklyn Investment Group ($75K) and IFP Advisors, Inc ($3K).
- Company
- Y-Mabs Therapeutics Inc.
- CUSIP
- 984241109
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 95 | $125.8M |
All 13F filers, Q2 2025 → Q3 2025: 11,110 shares bought and 27,899,565 shares sold, net −27,888,455 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Brooklyn Investment Group | 0.01% | Add +224.4% | 16,061 | $75K |
| IFP Advisors, Inc | 0.00% | Reduce -0.6% | 332 | $3K |
"% of holder's portfolio" is YMAB's weight in each manager's 13F, not the share of Y-Mabs Therapeutics Inc. the manager owns.